相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The RELIEF study: Tolerability and efficacy of preservative-free latanoprost in the treatment of glaucoma or ocular hypertension
Marta Misiuk-Hojlo et al.
EUROPEAN JOURNAL OF OPHTHALMOLOGY (2019)
Objective ocular surface tolerance in patients with glaucoma treated with topical preserved or unpreserved prostaglandin analogues
Ammar El Ameen et al.
EUROPEAN JOURNAL OF OPHTHALMOLOGY (2019)
Global Prevalence of Glaucoma and Projections of Glaucoma Burden through 2040 A Systematic Review and Meta-Analysis
Yih-Chung Tham et al.
OPHTHALMOLOGY (2014)
Prevalence of Ocular Surface Complaints in Patients With Glaucoma Using Topical Intraocular Pressure-Lowering Medications
Robert D. Fechtner et al.
CORNEA (2010)
Preservatives in eyedrops: The good, the bad and the ugly
Christophe Baudouin et al.
PROGRESS IN RETINAL AND EYE RESEARCH (2010)
Detrimental effect of preservatives in eyedrops: implications for the treatment of glaucoma
Christophe Baudouin
ACTA OPHTHALMOLOGICA (2008)
Microbial contamination of multiply used preservative-free artificial tears packed in reclosable containers
M. S. Kim et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2008)
Late-stage, primary open-angle glaucoma in Europe: Social and health care maintenance costs and quality of life of patients from 4 countries
J. Thygesen et al.
CURRENT MEDICAL RESEARCH AND OPINION (2008)
Ocular symptoms and signs with preserved and preservative-free glaucoma medications
N. Jaenen et al.
EUROPEAN JOURNAL OF OPHTHALMOLOGY (2007)
The number of people with glaucoma worldwide in 2010 and 2020
HA Quigley et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2006)
Corneal and conjunctival changes caused by commonly used glaucoma medications
RJ Noecker et al.
CORNEA (2004)
In vitro effects of preserved and unpreserved antiglaucoma drugs on apoptotic marker expression by human trabecular cells
P Hamard et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2003)
A 3-month comparison of efficacy and safety of brimonidine-purite 0.15% and brimonidine 0.2% in patients with glaucoma or ocular hypertension
T Mundorf et al.
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS (2003)
Reduction of intraocular pressure and glaucoma progression - Results from the early manifest glaucoma trial
A Heijl et al.
ARCHIVES OF OPHTHALMOLOGY (2002)
Twelve-month evaluation of brimonidine-purite versus brimonidine in patients with glaucoma or ocular hypertension
LJ Katz
JOURNAL OF GLAUCOMA (2002)
Comparison of the effects of preserved and unpreserved formulations of timolol on the ocular surface of albino rabbits
PJ Pisella et al.
OPHTHALMIC RESEARCH (2000)
分享论文
